Filings

Recent filings

Filing	Date
Recommendation by the Nomination Committee concerning Board of Directors to be elected by the AGM of Orion Corporation	30 Jan 2008
98,020 Orion A-shares converted into B-shares	28 Jan 2008
Positive primary endpoint from FIRST-STEP study with Stalevo in early Parkinson's Disease	24 Jan 2008
Orion Corporation publishes 2007 Financial Statement release on 7 Feb 2008 at 8.30 EET	16 Jan 2008
Orion comments on new challenge by Sun Pharmaceutical Industries Ltd., India, of Orion's U.S. Patent No. 5,446,194 covering its proprietary drug Stalevo® in the United States	2 Jan 2008
260,000 Orion A-shares converted into B-shares	17 Dec 2007
Announcement by Orion Corporation in accordance with section 10 of chapter 2 of the Finnish Securities Market Act	27 Nov 2007
Appointments into Orion s Executive Management Board as of 1 January 2008	15 Nov 2007
Orion sues Sun Pharmaceuticals in the U.S. to enforce a patent for Stalevo®	13 Nov 2007
171,347 Orion A-shares converted into B-shares	7 Nov 2007
Orion Corporation s publication schedules for financial reporting in 2008	24 Oct 2007
Orion Group Interim Report 1-9/2007	24 Oct 2007

ORION B